View on Pubmed.gov 38296309 | View on doi.org 10.1136/rmdopen...
Dynamics of inflammation-associated plasma proteins following faecal microbiota transplantation in patients with psoriatic arthritis and healthy controls: exploratory findings from the FLORA trial.
- Department of Rheumatology, Odense University Hospital, Odense, Denmark maja.kragsnaes@dadlnet.dk.
- Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
- Department of Mathematics and Computer Science (IMADA), University of Southern Denmark, Odense, Denmark.
- Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
- Department of Rheumatology, Odense University Hospital, Odense, Denmark.
- Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark.
- BioXpedia A/S, Aarhus, Denmark.
- Department of Biology, Laboratory of Genomics and Molecular Biomedicine, University of Copenhagen, Copenhagen, Denmark.
- Institute of Metagenomics, Qingdao-Europe Advanced Institute for Life Sciences, Qingdao, China.
- Division of Digestive Diseases, Imperial College London Faculty of Medicine, London, UK.
- Department of Gastroenterology and Hepatology, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.
- Department of Medical Gastroenterology, Odense University Hospital, Odense, Denmark.
Abstract
OBJECTIVES
The gut microbiota can mediate both pro and anti-inflammatory responses. In patients with psoriatic arthritis (PsA), we investigated the impact of faecal microbiota transplantation (FMT), relative to sham transplantation, on 92 inflammation-associated plasma proteins.
METHODS
This study relates to the FLORA trial cohort, where 31 patients with moderate-to-high peripheral PsA disease activity, despite at least 3 months of methotrexate treatment, were included in a 26-week, double-blind, randomised, sham-controlled trial. Participants were allocated to receive either one gastroscopic-guided healthy donor FMT (n=15) or sham (n=16). Patient plasma samples were collected at baseline, week 4, 12 and 26 while samples from 31 age-matched and sex-matched healthy controls (HC) were collected at baseline. Samples were analysed using proximity extension assay technology (Olink Target-96 Inflammation panel).
RESULTS
Levels of 26 proteins differed significantly between PsA and HC pre-FMT (adjusted p<0.05), of which 10 proteins were elevated in PsA: IL-6, CCL20, CCL19, CDCP1, FGF-21, HGF, interferon-γ (IFN-γ), IL-18R1, monocyte chemotactic protein 3, and IL-2. In the FMT group, levels of 12 proteins changed significantly across all timepoints (tumour necrosis factor (TNF), CDCP1, IFN-γ, TWEAK, signalling lymphocytic activation molecule (SLAMF1), CD8A, CD5, Flt3L, CCL25, FGF-23, CD6, caspase-8). Significant differences in protein levels between FMT and sham-treated patients were observed for TNF (p=0.002), IFN-γ (p=0.011), stem cell factor (p=0.024), matrix metalloproteinase-1 (p=0.038), and SLAMF1 (p=0.042). FMT had the largest positive effect on IFN-γ, Axin-1 and CCL25 and the largest negative effect on CCL19 and IL-6.
CONCLUSIONS
Patients with active PsA have a distinct immunological plasma protein signature compared with HC pre-FMT. FMT affects several of these disease markers, including sustained elevation of IFN-γ.
TRIAL REGISTRATION NUMBER
NCT03058900.
References
Hepatol Int. 2022 Apr;16(2):433-446
Gut Microbes. 2019;10(2):142-148
Ann Rheum Dis. 2020 Jun;79(6):778-786
J Physiol Pharmacol. 2016 Dec;67(6):859-866
Cited by 9 citations (total)
Journal Article Review
Fecal microbiota transplantation-current perspective on human health.
Electronic publication date March 31, 2025
Zixuan Cao [...] Xingxing Yuan et al.
Recently, microbiome medicine has attracted the attention of researchers. While this rapidly growing medical approach for various diseases and disorders...
Journal Article Review
Fecal microbiota transplantation for the treatment of intestinal and extra-intestinal diseases: Mechanism basis, clinical application, and potential prospect.
Electronic publication date March 10, 2025
Dongxin Yi [...] Ningning Wang et al.
To review the theoretical basis and therapeutic effects of fecal microbiota transplantation (FMT) in various diseases in animal experiments and...
Conflict of interest statement
Competing interests: BHM has received consultancy fees from Finch Therapeutics Group, outside of the submitted work. JRM has received consultancy fees from Cultech Ltd., and Enterobiotix Ltd., outside of the submitted work.
MeSH
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
Substances
- •
- •
- •
- •
Copyright
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.